Clinical Trial Update: Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the effect of dapagliflozin on recurrence of atrial tachyarrhythmia in patients undergoing catheter ablation for atrial fibrillation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Tachyarrhythmia

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Atrial Fibrillation Recurrent, Catheter Ablation | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING